Clinical Trial Update: Study Investigating Administration of Prevenar for Post-Marketing Surveillance

View source ↗

Summary

A completed post-marketing surveillance clinical trial evaluating the administration of Prevenar, a pneumococcal conjugate vaccine, for pneumococcal infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Drugs mentioned

• Prevenar (pneumococcal conjugate vaccine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Pneumococcal Infections | Status: COMPLETED